A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Axogen, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,400 shares of AXGN stock, worth $178,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,400
Holding current value
$178,776
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $14.69 $78,208 - $152,776
10,400 New
10,400 $145,000
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $238,000 - $290,640
28,000 New
28,000 $255,000
Q4 2022

Feb 14, 2023

BUY
$9.44 - $13.09 $140,656 - $195,041
14,900 New
14,900 $148,000
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $62,211 - $89,000
-8,900 Reduced 27.81%
23,100 $189,000
Q1 2022

May 16, 2022

SELL
$7.26 - $10.7 $108,900 - $160,500
-15,000 Reduced 31.91%
32,000 $254,000
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $144,320 - $262,400
16,400 Added 53.59%
47,000 $440,000
Q3 2021

Nov 15, 2021

SELL
$15.23 - $21.72 $654,890 - $933,960
-43,000 Reduced 58.42%
30,600 $483,000
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $213,600 - $282,000
12,000 Added 19.48%
73,600 $1.59 Million
Q1 2021

May 17, 2021

BUY
$17.18 - $22.6 $173,518 - $228,260
10,100 Added 19.61%
61,600 $1.25 Million
Q4 2020

Feb 16, 2021

BUY
$11.5 - $17.96 $147,200 - $229,888
12,800 Added 33.07%
51,500 $922,000
Q3 2020

Nov 16, 2020

SELL
$10.62 - $13.12 $498,077 - $615,328
-46,900 Reduced 54.79%
38,700 $450,000
Q2 2020

Aug 14, 2020

BUY
$7.35 - $10.81 $629,160 - $925,336
85,600 New
85,600 $791,000
Q1 2020

May 15, 2020

SELL
$8.38 - $17.34 $126,538 - $261,834
-15,100 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $906,698 - $1.51 Million
-81,100 Reduced 84.3%
15,100 $270,000
Q3 2019

Nov 14, 2019

BUY
$12.09 - $20.46 $53,196 - $90,024
4,400 Added 4.79%
96,200 $1.2 Million
Q2 2019

Aug 14, 2019

SELL
$18.5 - $25.47 $736,300 - $1.01 Million
-39,800 Reduced 30.24%
91,800 $1.82 Million
Q1 2019

May 15, 2019

BUY
$14.62 - $22.13 $1.23 Million - $1.86 Million
84,200 Added 177.64%
131,600 $2.77 Million
Q4 2018

Feb 14, 2019

BUY
$17.09 - $38.25 $75,196 - $168,300
4,400 Added 10.23%
47,400 $968,000
Q3 2018

Nov 14, 2018

SELL
$34.05 - $55.9 $1.77 Million - $2.9 Million
-51,900 Reduced 54.69%
43,000 $1.59 Million
Q2 2018

Aug 14, 2018

SELL
$36.15 - $52.5 $2.23 Million - $3.24 Million
-61,800 Reduced 39.44%
94,900 $4.77 Million
Q1 2018

May 15, 2018

BUY
$24.4 - $40.25 $980,880 - $1.62 Million
40,200 Added 34.51%
156,700 $5.72 Million
Q4 2017

Feb 14, 2018

BUY
$18.5 - $28.6 $825,100 - $1.28 Million
44,600 Added 62.03%
116,500 $3.3 Million
Q3 2017

Nov 14, 2017

BUY
$14.65 - $19.35 $1.05 Million - $1.39 Million
71,900
71,900 $1.39 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $727M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.